Business
Pharmagen Enters into Financial Advisory Agreement with Merriman Capital, Inc.
Pharmagen Enters into Financial Advisory Agreement with Merriman Capital, Inc..
About this update from Merriman Holdings Inc
[{"type":"text","content":"\n\n\n\n\n\n\n\nPharmagen Enters into Financial Advisory Agreement with Merriman Capital, Inc.\n\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:\"0in\";\n}\n\n\n\n\n\n\n\n\n\n\nPharmagen Enters into Financial Advisory Agreement with Merriman Capital, Inc.\n\nPR Newswire\n\nSILVER SPRING, Md., March 4, 2013\n\n\n\n\n\n\n\nSILVER SPRING, Md., March 4, 2013 /PRNewswire/ -- Pharmagen, Inc. (OTCBB: PHRX) (the \"Company\" or \"Pharmagen\") announces it has entered into a financial advisory agreement with Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR). Merriman Capital, Inc. is a registered investment bank providing equity and options execution services, market making, and differentiated research for high growth companies. The firm also provides capital raising, advisory, and M&A services. Under the terms of the agreement, Merriman has agreed to provide Pharmagen with a wide range of services from equity research coverage, participation in the Merriman's annual investor conference, non-deal road shows and eligibility criteria for admission to NASDAQ and other exchanges. Merriman is the leading investment banking firm for micro-cap companies.\n\n\n\"Pharmagen continues to demonstrate to our shareholders that we are building a company for the long term. Merriman is the leading advisory firm to companies in our market cap range and we're going to work very hard over the coming year to build an institutional shareholder base. Merriman is going to ensure that we're doing it in a way that will resonate with that community,\" said Mackie A. Barch, CEO of Pharmagen. \n\n\n\nAbout Pharmagen\n\n\n\nPharmagen, Inc. (\"Pharmagen\"), and wholly owned subsidiaries and operating divisions Pharmagen Laboratories, Inc., Pharmagen Distribution, LLC and Pharmagen Nutraceuticals, Inc. is the leader in innovative solutions to the nations sterile pharmaceutical crisis. With a multifaceted approach, Pharmagen is meeting the demand of health provider market through dynamic, independent wholesale, compounding, and innovative IT solutions. Nationally focused,...